Fidelity Investments’s KORU Medical Systems KRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.9K Buy
5,680
+2,914
+105% +$11.9K ﹤0.01% 4601
2026
Q1
$11.9K Sell
2,766
-5,928
-68% -$29.4K ﹤0.01% 4707
2025
Q4
$50.5K Buy
8,694
+7,471
+611% +$35.8K ﹤0.01% 4107
2025
Q3
$4.68K Buy
1,223
+170
+16% +$650 ﹤0.01% 4799
2025
Q2
$3.77K Sell
1,053
-1,491
-59% -$4.24K ﹤0.01% 4760
2025
Q1
$6.46K Hold
2,544
﹤0.01% 4630
2024
Q4
$9.79K Hold
2,544
﹤0.01% 4469
2024
Q3
$6.95K Sell
2,544
-99
-4% -$244 ﹤0.01% 4535
2024
Q2
$7K Buy
2,643
+555
+27% +$1.27K ﹤0.01% 4447
2024
Q1
$4.93K Sell
2,088
-1,501
-42% -$3.22K ﹤0.01% 4513
2023
Q4
$8.81K Buy
3,589
+2,362
+193% +$5.63K ﹤0.01% 4277
2023
Q3
$3.31K Buy
1,227
+1,162
+1,788% +$3.18K ﹤0.01% 4425
2023
Q2
$224 Buy
+65
New +$255 ﹤0.01% 4889
2022
Q1
Sell
-38
Closed 5257
2021
Q4
$0 Buy
+38
New +$117 ﹤0.01% 4685
2021
Q3
Sell
-1,001
Closed -$5K 4723
2021
Q2
$5K Buy
+1,001
New +$3.93K ﹤0.01% 3730

Other funds holding KRMD

Fidelity Investments's KRMD Position: Q2 2026 in Review

Fidelity Investments increased its KORU Medical Systems (KRMD) stake by 105% in Q2 2026, buying an estimated $11.9K and bringing the position to 5,680 shares worth $23.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4601.

Fidelity Investments first reported a position in KRMD in Q2 2021 and has held it in 15 quarters since. The position peaked at $50.5K in Q4 2025. 85 funds tracked by Wall St. Rank hold KRMD as of Q2 2026.

  • Fidelity Investments held 5,680 shares of KORU Medical Systems worth $23.9K as of Q2 2026.
  • Fidelity Investments bought 2,914 KORU Medical Systems shares in Q2 2026, an estimated $11.9K.
  • KORU Medical Systems made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #4601 holding.
  • Fidelity Investments first reported a position in KORU Medical Systems in Q2 2021 and has held it in 15 quarters since.
  • Fidelity Investments's KORU Medical Systems position peaked at $50.5K in Q4 2025.
  • 85 funds tracked by Wall St. Rank held KORU Medical Systems as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.